BioNTech SE - ADR vs Commvault Systems Inc — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while Commvault Systems Inc trades at $139 (market cap $5.78B). The key difference: BioNTech SE - ADR is far larger — about 4× Commvault Systems Inc's market cap, and Commvault Systems Inc is trading nearer its 52-week high, BioNTech SE - ADR nearer its low. Which is the better fit depends on your goals.
| BNTX | CVLT | |
|---|---|---|
Market Cap | $23.31B | $5.78B |
Sector | Health | Technology |
52-Week High | $119.34 | $195.41 |
52-Week Low | $83.89 | $75.18 |
Enterprise Value | $6.60B | $5.76B |
Trailing returns across standard periods
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →Commvault provides enterprise-grade data protection and information management software. Its platform helps businesses manage, back up, and recover data across on-premises, cloud, and hybrid environments.
Read more on CVLT →